Goldman Sachs maintained a Neutral rating on Vertex (NASDAQ: VRTX) with a price target of $64.00.Analyst Terence Flynn said ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View

Vertex (VRTX): H.C. Wainwright Comments on VX-661 DataMay 2, 2014 9:33 AM Vertex (VRTX) Bullish Stance Reiterated at Needham & Company after Q1 Results, Encouraging VX-661-Ivacaftor Phase 2 DataMay 2, 2014 7:41 AM Vertex Pharmaceuticals, Inc. (VRTX) Posts Q1 Loss of 65c/Share; Reports Statistically Significant KALYDECO + VX-661 Ph. 2 DataMay 1, 2014 4:09 PM